Your Article Summary
See Latest ArticlesTargeted Therapy for Malignant Glioma Patients: Lessons Learned and the Road Ahead
Neurotherapeutics, 07/02/09
Huang TT et al. - Molecularly targeted therapies are transforming the care of patients with malignant gliomas, including glioblastoma, the most common malignant primary brain tumor of adults. With an arsenal of small molecule inhibitors and antibodies that target key components of the signal transduction machinery that are commonly activated in gliomas, neuro-oncologists and neurosurgeons are poised to transform the care of these patients.
Related Articles
Functional and work outcomes improve in patients with rheumatoid arthritis who receive targeted, comprehensive occupational therapy
Arthritis Care and Research, 11/05/09
Relevance Score: 68%
Acute renal failure in septic patients: Epidemiology, diagnosis and therapy
Intensivmedizin und Notfallmedizin, 11/06/09
Relevance Score: 67%
Beta 1 integrin targeting to enhance radiation therapy
International Journal of Radiation Biology, 11/05/09
Relevance Score: 67%
Galectin-3 Targeted Therapy with a Small Molecule Inhibitor Activates Apoptosis and Enhances Both Chemosensitivity and Radiosensitivity in Papillary Thyroid Cancer
Molecular Cancer Research, 10/20/09
Relevance Score: 67%
Targeted radionuclide therapy in head and neck cancer
Head & Neck, 10/15/09
Relevance Score: 67%
Today in Neurologic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Quantitative F18-fluorodeoxyglucose positron emission tomography accurately characterizes peripheral nerve sheath tumors as malignant or benign
Cancer, 11/30/09
Radiosurgery and whole brain therapy in the treatment of brainstem metastases
Clinical and Translational Oncology, 11/30/09
Treatment of Cerebellopontine Angle Tumors in Children: A Single Institution's Experience
Journal of Pediatric Hematology/Oncology, 11/30/09